Growth Metrics

Merck (MRK) Long-Term Deferred Tax (2016 - 2023)

Merck (MRK) has disclosed Long-Term Deferred Tax for 14 consecutive years, with $10.2 billion as the latest value for Q2 2023.

  • Quarterly Long-Term Deferred Tax fell 7.15% to $10.2 billion in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $10.2 billion through Jun 2023, down 7.15% year-over-year, with the annual reading at $9.5 billion for FY2022, 17.73% down from the prior year.
  • Long-Term Deferred Tax for Q2 2023 was $10.2 billion at Merck, down from $10.3 billion in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $11.6 billion in Q4 2021, with the low at $6.8 billion in Q4 2019.
  • Average Long-Term Deferred Tax over 5 years is $9.6 billion, with a median of $9.7 billion recorded in 2020.
  • The sharpest move saw Long-Term Deferred Tax fell 19.01% in 2020, then soared 48.7% in 2021.
  • Over 5 years, Long-Term Deferred Tax stood at $6.8 billion in 2019, then surged by 45.93% to $9.9 billion in 2020, then increased by 17.21% to $11.6 billion in 2021, then dropped by 17.73% to $9.5 billion in 2022, then grew by 6.92% to $10.2 billion in 2023.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $10.2 billion, $10.3 billion, and $9.5 billion for Q2 2023, Q1 2023, and Q4 2022 respectively.